These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6135434)

  • 1. Comparative investigations on the cardiovascular effects of Org NC45 and pancuronium in dogs.
    Fitzal S; Gilly H; Ilias W
    Br J Anaesth; 1983 Jul; 55(7):641-6. PubMed ID: 6135434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular and neuromuscular effects of Org NC 45, pancuronium, metocurine, and d-tubocurarine in dogs.
    Booij LH; Edwards RP; Sohn YJ; Miller RD
    Anesth Analg; 1980 Jan; 59(1):26-30. PubMed ID: 7188662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effects of Org NC 45 and pancuronium bromide on heart rate and arterial pressure in anaesthetized man.
    Barnes PK; Smith GB; White WD; Tennant R
    Br J Anaesth; 1982 Apr; 54(4):435-9. PubMed ID: 6121570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative potency of ORG NC 45, pancuronium, alcuronium and tubocurarine in anaesthetized man.
    Krieg N; Crul JF; Booij LH
    Br J Anaesth; 1980 Aug; 52(8):783-8. PubMed ID: 6107097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular effects of pancuronium bromide in mongrel dogs.
    Reitan JA; Warpinski MA
    Am J Vet Res; 1975 Sep; 36(9):1309-11. PubMed ID: 1163867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac effects of vecuronium and pancuronium during halothane anaesthesia.
    Engbaek J; Ording H; Sørensen B; Viby-Mogensen J
    Br J Anaesth; 1983 Jun; 55(6):501-5. PubMed ID: 6134536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular and vagal blocking actions of pancuronium bromide, its metabolites, and vecuronium bromide (Org NC45) and its potential metabolites in the anaesthetized cat.
    Marshall IG; Gibb AJ; Durant NN
    Br J Anaesth; 1983 Aug; 55(8):703-14. PubMed ID: 6136285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical studies on Org NC 45: comparison with pancuronium.
    Kerr WJ; Baird WL
    Br J Anaesth; 1982 Nov; 54(11):1159-65. PubMed ID: 6128012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuromuscular blocking action of ORG NC 45, a new pancuronium derivative, in anaesthetized patients. A pilot study.
    Agoston S; Salt P; Newton D; Bencini A; Boomsma P; Erdmann W
    Br J Anaesth; 1980; 52 Suppl 1():53S-59S. PubMed ID: 6107107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of ORG NC45 (NorcuronTM): a new nondepolarizing muscle relaxant.
    Fahey MR; Morris RB; Miller RD; Sohn YJ; Cronnelly R; Gencarelli P
    Anesthesiology; 1981 Jul; 55(1):6-11. PubMed ID: 6113794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the neuromuscular blocking and vagolytic effects of ORG NC45 and pancuronium.
    Son SL; Waud BE; Waud DR
    Anesthesiology; 1981 Jul; 55(1):12-8. PubMed ID: 6113793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart rate and blood pressure changes after ORG NC45 (vecuronium) and pancuronium during halothane and enflurane anesthesia.
    Gregoretti SM; Sohn YJ; Sia RL
    Anesthesiology; 1982 May; 56(5):392-5. PubMed ID: 6122389
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of vecuronium and pancuronium on cardiac performance and transmural myocardial perfusion during ketamine anaesthesia.
    Pedersen T; Engbaek J; Ording H; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1984 Aug; 28(4):443-6. PubMed ID: 6148830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response relation for atracurium, ORG NC 45 and pancuronium.
    Gramstad L; Lilleaasen P
    Br J Anaesth; 1982 Jun; 54(6):647-51. PubMed ID: 6123339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antagonism of org NC 45 (vecuronium) and pancuronium neuromuscular blockade by neostigmine.
    Gencarelli PJ; Miller RD
    Br J Anaesth; 1982 Jan; 54(1):53-6. PubMed ID: 6119998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of vecuronium, atracurium, pancuronium, metocurine and RGH-4201 in dogs.
    Hackett GH; Jantzen JP; Earnshaw G
    Acta Anaesthesiol Scand; 1989 May; 33(4):298-303. PubMed ID: 2566252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the cardiovascular actions of ORG NC 45 with those produced by other non-depolarizing neuromuscular blocking agents in experimental animals.
    Marshall RJ; McGrath JC; Miller RD; Docherty JR; Lamar JC
    Br J Anaesth; 1980; 52 Suppl 1():21S-32S. PubMed ID: 6107101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cardiovascular effects of vecuronium (ORG NC45) and pancuronium in patients undergoing coronary artery bypass grafting.
    Morris RB; Cahalan MK; Miller RD; Wilkinson PL; Quasha AL; Robinson SL
    Anesthesiology; 1983 May; 58(5):438-40. PubMed ID: 6132568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of doxacurium, pancuronium and vecuronium in anaesthetized patients presenting for coronary artery bypass surgery.
    Emmott RS; Bracey BJ; Goldhill DR; Yate PM; Flynn PJ
    Br J Anaesth; 1990 Oct; 65(4):480-6. PubMed ID: 1979009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intubation conditions and reversibility of a new non-depolarizing neuromuscular blocking agent, Org-NC45.
    Krieg N; Mazur L; Booij LH; Crul JF
    Acta Anaesthesiol Scand; 1980 Oct; 24(5):423-5. PubMed ID: 6110303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.